CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use the original agreement and policy sources for this record to identify the exact clause, its legal source, and the stated consequence. Preserve those facts before reaching a conclusion about a particular provider or condition.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
NEVADA · CONTRACT FOR CARE
Nevada Advanced Pain Specialists — Contract Versus Nevada Law
Which conditions come from Nevada law, which come from Nevada Advanced Pain Specialists, and what does this document say happens when a patient cannot meet them?
What Nevada requires
For covered pain prescribing of Schedule II–IV controlled substances intended to last more than 30 days, NRS639.23914 requires an agreement within 30 days after the initial prescription, recorded and updated every 365 days or when the plan changes. Its required subjects include goals, medically necessary testing consent, prescribed use, no sharing, specified disclosures, random pill-count authorization and reasons medication treatment may change or stop.
Section2(h) permits practitioners to impose additional requirements. Permission to add a condition does not make that condition a statewide requirement. Cancer, sickle-cell disease/variants, hospice and palliative care have statutory exceptions. Read the full state baseline and scope.
State requirement → office condition → stated consequence
Selected access-related conditions. Read exact wording in the original source at each page/section reference. This table is not an exhaustive transcription or compliance audit.
| Condition | What the state requires | What the practice adds or specifies | If you refuse or cannot comply |
|---|---|---|---|
| Cannabis and 50 MME PDF p.17, items43–44 | Alcohol/cannabis use must be disclosed (§639.23914(2)(e)(2)); this agreement provision does not require abstinence or a marijuana card. | Medical marijuana card within 90 days; card holders capped at 50 MME under this office policy. Institution-specific policy | Without card after 90 days and positive screen, narcotics discontinued. |
| Sedatives and 50 MME PDF p.17, item45; p.10 companion policy | §639.23913 requires review/revised plans in its 90-MME pathway, not this clinic’s 50-MME cap. | Specialist necessity letter, excluding primary care, for sedatives; with letter, maximum 50 MME. Institution-specific policy | Without letter, opioid treatment will not start or will stop. |
| 24-hour pill count PDF p.17, item47 | The agreement must authorize random pill counts (§639.23914(2)(f)); it specifies no 24-hour return deadline. | Attend within 24 hours when called between visits. Required subject / implementation discretionary | Failure forfeits future narcotic prescriptions. |
| Testing attendance PDF p.17, item46 | Testing consent is mandatory when the practitioner deems testing medically necessary (§639.23914(2)(b)); the statute sets no fixed frequency or fee. | Mandatory/random screens; do not leave before sample. Required subject / implementation discretionary | Leaving forfeits future narcotic prescriptions. |
| Behavioral referral PDF p.17, item48 | §639.23914(2)(h) permits practitioner additions; it does not prescribe this specific condition. | Nonadherence to any agreement item triggers a mandatory behavioral-health referral. Institution-specific policy | Referral; discretionary clinic dismissal separately stated. |
| Telephone and visits PDF pp.16–17, items32–33,38–40 | The refill approach must be explained in informed consent (§639.23912(2)(g)); these provisions do not prescribe this office’s schedule. | More than two daily calls treated as harassment; no unannounced refill visit; no medicine for cancelled/no-show visits. Institution-specific policy | Rescheduling/no medicine; general dismissal provision. |
| Lost/stolen medicine PDF p.17, item36 | NAC639.836 does not interpret the PMP provision as prohibiting replacement. | No replacement under any circumstances. Institution-specific policy | No replacement supply under this printed rule. |
| Kratom and alcohol PDF p.17, items41–42 | §639.23914(2)(h) permits practitioner additions; it does not prescribe this specific condition. | Kratom prohibited; alcohol prohibited during narcotic prescribing. Institution-specific policy | Alcohol-positive screening may lead to narcotic discontinuation. |
Check the original document and its version
Open the original 33-page document · See the practice’s public forms/source page
Version: Public packet named 2024 in a 2024/06 upload path; agreement revision date unverified.
Pages 13–14 contain a general medication agreement; pages 16–19 contain a controlled-substance agreement and risk notice. Page 10 has an additional opioid/benzodiazepine policy. These sections are distinguished. Current signed use is unconfirmed.
Separate public opioid-policy notice
Offices connected with this practice
The public document is linked at practice level. Its applicability at each office and to particular patients requires confirmation.
- Nevada Advanced Pain Specialists — Reno: 5578 Longley Lane, Reno, NV 89511
- Nevada Advanced Pain Specialists — Sparks: 2385 E Prater Way, #204, Sparks, NV 89434
- Nevada Advanced Pain Specialists — Carson City: 2874 N Carson Street, Suite 220, Carson City, NV 89706
Supply the missing evidence or correct a fact
Patients and the public may submit a blank or de-identified agreement, including older versions. Authorized practice representatives may correct facts, supply the operative document, explain applicable offices/patient groups, and identify effective dates. Submissions are checked before public updates; meaningful historical evidence is retained.
Primary legal sources
NRS639.23914: agreement contents · NRS639.23912: informed consent · NRS639.23913: 90-day review · NAC639.836/.838: replacement interpretation and group implementation
Evidence boundary: Publicly linked does not mean practice-confirmed current signed use. The condition comparisons are document summaries, not observed patient outcomes. “Added by the practice” means the reviewed agreement authority does not prescribe that specific condition; medical justification and enforceability are separate questions. No office is ranked and no illegality finding is made. Research/retrieval: October 13, 2026 UTC (October 12 Central).